zuChem introduces custom synthesis services

zuChem, from Chicago, an innovative supplier of glycochemicals and other specialised sugars for the pharmaceutical and other industries, will offer custom synthesis of rare and modified glycochemicals using its proprietary bioprocess technology.

This new service is aimed at providing a large and motivated research market with a cost-effective source of glycochemical building blocks for drug discovery and development.

'Pharmaceutical products that incorporate glycochemicals have tremendous therapeutic potential, however, only a small number of natural glycochemicals are available as starting research materials and synthetic glycochemicals are expensive and rarely available,' said David Demirjian, president of zuChem. 'Our custom synthesis services will make these novel pharmaceutical building blocks readily available, at economically viable prices.'

Glycochemicals have a variety of current and future applications including drugs for the treatment of type II diabetes, viral-infections, and cancer metastases. Glycochemicals also play an important role in many antibiotics.

zuChem will provide custom synthesis of a wide variety of molecules, including rare L-sugars derivatives and other unusual glycochemicals. The company's fully staffed research facilities, located in Peoria Illinois, are equipped for: small molecule glycosylation, microbial fermentation, biotransformation, as well as other focused services.